Literature DB >> 22222285

List of drugs in development for neurodegenerative diseases: update October 2011.

Vanda Pogačić Kramp1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22222285     DOI： 10.1159/000335520

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN： 1660-2854            Impact factor:   2.977


× No keyword cloud information.
  6 in total

Review 1.  Tau-induced neurodegeneration: mechanisms and targets.

Authors:  Cindy Beharry; Leah S Cohen; Jing Di; Kawsar Ibrahim; Susan Briffa-Mirabella; Alejandra del C Alonso
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

2.  Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior.

Authors:  Fei Geng; Jia Tian; Jian-Lin Wu; Yun Luo; Wen-Jun Zou; Chao Peng; Gui-Feng Lu
Journal:  Cogn Affect Behav Neurosci       Date:  2018-02       Impact factor: 3.282

3.  Arizona Alzheimer's Registry: Strategy and Outcomes of a Statewide Research Recruitment Registry.

Authors:  K T Saunders; J B Langbaum; C J Holt; W Chen; N High; C Langlois; M Sabbagh; P N Tariot
Journal:  J Prev Alzheimers Dis       Date:  2014-09

Review 4.  Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.

Authors:  Laurent Calcul; Bo Zhang; Umesh K Jinwal; Chad A Dickey; Bill J Baker
Journal:  Future Med Chem       Date:  2012-09       Impact factor: 3.808

Review 5.  Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings.

Authors:  Pallavi Duggal; Sidharth Mehan
Journal:  J Alzheimers Dis Rep       Date:  2019-07-02

Review 6.  Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?

Authors:  Karen Claesen; Joachim C Mertens; Dorien Leenaerts; Dirk Hendriks
Journal:  Int J Mol Sci       Date:  2021-01-17       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.